Kim, K., Saeed, A., Iyer, R., Kim, R. D., Feun, L. G., Kumar, S. (2025). A multicenter, open-label study investigating RP2 oncolytic immunotherapy in combination with second-line systemic atezolizumab plus bevacizumab in patients with locally advanced unresectable or metastatic hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps649